Results 151 to 160 of about 79,649 (298)

Application of kDNA as a molecular marker to analyse Leishmania infantum diversity in Portugal.

, 2006
Around the Mediterranean basin Leishmania infantum is an important parasite causing canine leishmaniasis and visceral and cutaneous clinical forms in both immunocompetent and immunocompromised humans.
Almeida, Ana, Campino, Lenea, Cortes, Sofia, Cristovão, José Manuel, Dedet, Jean Pierre, Mauricio, Isabel, Pratlong, Francine   +6 more
core   +1 more source

Regulation of immunity during visceral Leishmania infection [PDF]

, 2016
Unicellular eukaryotes of the genus Leishmania are collectively responsible for a heterogeneous group of diseases known as leishmaniasis. The visceral form of leishmaniasis, caused by L. donovani or L.
A Caldas, A Campos-Neto, A Cope, A Gallimore, A Hammami, A Maroof, A Maroof, A Nieto, A Schietinger, AC Ghose, AC Stanley, AC Stanley, AJ Zajac, AM Mangoud, Anabela Cordeiro-da-Silva, AP Freitas do Rosario, B Galvao-Castro, BM Owens, BN Thomas, BT Edelson, BT Edelson, C Trez De, C Zaph, CR Engwerda, CR Engwerda, CR Engwerda, CR Engwerda, CR Engwerda, CR Engwerda, D Jankovic, D Nandan, DA Vignali, DL Sacks, DR Faria, E Cillari, EJ Wherry, EJ Wherry, EM Carvalho, F Chappuis, F Real, F Robert-Gangneux, F Woelbing, FO Novais, G Arango Duque, G Matlashewski, GD Victora, GR Cooper, H Aslan, HT Jin, HT Jin, HW Murray, HW Murray, HW Murray, HW Murray, HW Murray, HW Murray, HW Murray, HW Murray, HW Murray, I Muller, I Muller, I Vouldoukis, J Alvar, J Chavas, J Griensven van, J Lehmann, J Zhu, JE Dalton, JG Cyster, JJ Stern, JL Amprey, JP Gigley, JS Cervia, JS Yi, JW Moore, Jérôme Estaquier, K Ghosh, KE Squires, KJ Esch, KN Gibson-Corley, KN Gibson-Corley, L Beattie, L Beattie, L Beattie, LE Rosas, LE Rosas, LE Smith, LU Buxbaum, M Ato, M Barral-Netto, M Guilliams, M Olivier, M Resende, M Saraiva, M Svensson, M Svensson, MA Nolte, MC Cumont, MC Tumang, ME Wilson, ME Wilson, MG Pitta, Mireille Laforge, MJ McElrath, ML Murphy, ML Murphy, MM Kane, MS Nascimento, N Rolao, N Santarem, NA Ansari, NA Gomes, ND Glennie, OP Singh, OP Singh, P Gallo, P Kaye, P Tsagozis, P Tsagozis, P Yurdakul, PA Kager, PM Gorak, PM Kaye, PT Bunn, R Badaro, R Bankoti, R Kumar, R Phillips, R Polley, R Polley, R Polley, R Porrozzi, RD Pearson, RE Mebius, Ricardo Silvestre, RJ Faleiro, RT Kenney, S Bhattacharyya, S Crotty, S Gautam, S Gautam, S Honore, S Ito, S Karmakar, S Kaur, S Lopez Kostka, S Nakayamada, S Nylen, S Nylen, S Oghumu, S Santos Cda, S Stager, S Stager, SA Costa Lima, SA Miles, SC Smelt, SC Smelt, SE Cotterell, SL Colpitts, SM Kaech, T Joshi, V Diniz-Atayde, V Leclercq, V Peruhype-Magalhaes, V Rodrigues, Vasco Rodrigues, VL Matta da, W Ouyang, WE Agu, WG Shreffler, Y Belkaid   +170 more
core   +4 more sources

Comprehensive proteomics analysis of glycosomes from Leishmania donovani.

Omics, 2015
Leishmania donovani is a kinetoplastid protozoan that causes a severe and fatal disease kala-azar, or visceral leishmaniasis. L. donovani infects human host after the phlebotomine sandfly takes a blood meal and resides within the phagolysosome of ...
Mahendra D Jamdhade, Harsh Pawar, S. Chavan, G. Sathe, P. K. Umasankar, K. Mahale, Tanwi Dixit, Anil K. Madugundu, T. Prasad, H. Gowda, A. Pandey, M. Patole   +11 more
semanticscholar   +1 more source

Structures, targets and recent approaches in anti-leishmanial drug discovery and development. [PDF]

, 2011
Recent years have seen a significant improvement in available treatment options for leishmaniasis. Two new drugs, miltefosine and paromomycin, have been registered for the treatment of visceral leishmaniasis (VL) in India since 2002.
Seifert, Karin
core   +2 more sources

Leishmania Donovani; Partial Characterization of Some Flagellate Cytoplasmic Immunogens [PDF]

, 1972
Bruce A. Clinton, Nicholas C. Palczuk, Leslie A. Stauber   +2 more
openalex   +1 more source

Polymerase chain reaction detection of Leishmania DNA in skin biopsy samples in Sri Lanka where the causative agent of cutaneous leishmaniasis is Leishmania donovani

Memórias do Instituto Oswaldo Cruz, 2015
Leishmania donovani is the known causative agent of both cutaneous (CL) and visceral leishmaniasis in Sri Lanka. CL is considered to be under-reported partly due to relatively poor sensitivity and specificity of microscopic diagnosis.
Shalindra Ranasinghe, R. Wickremasinghe, S. Hulangamuwa, G. Sirimanna, N. Opathella, R. Maingon, V. Chandrasekharan   +6 more
semanticscholar   +1 more source

Genetic control of natural resistance to Leishmania donovani (reply) [PDF]

, 1974
PLANT, GLYNN
openalex   +1 more source

Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis

Scientific Reports, 2015
Visceral leishmaniasis caused by Leishmania donovani is the most severe systemic form of the disease. There are still no vaccines available for humans and there are limitations associated with the current therapeutic regimens for leishmaniasis. Recently,
S. Anand, R. Madhubala
semanticscholar   +1 more source

Activity of purine analogs against Leishmania donovani in vivo [PDF]

, 1987
J D Berman, William L. Hanson, James K. Lovelace, Virginia B. Waits, Joan E. Jackson, Willie L. Chapman, Robert S. Klein   +6 more
openalex   +1 more source

Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. [PDF]

, 1982
Henry W. Murray
openalex   +1 more source